Cargando…
Pembrolizumab (MK-3475) in combination with lenalidomide and low-dose dexamethasone for relapsed/refractory multiple myeloma (RRMM): KEYNOTE-023
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646042/ http://dx.doi.org/10.1186/2051-1426-3-S2-P160 |
| _version_ | 1782400910085849088 |
|---|---|
| author | Mateos, Maria-Victoria Siegel, David Shah, Jatin J Reece, Donna Avigan, David Orlowski, Robert Ge, Yang Balakumaran, Arun Marinello, Patricia Miguel, Jesus San |
| author_facet | Mateos, Maria-Victoria Siegel, David Shah, Jatin J Reece, Donna Avigan, David Orlowski, Robert Ge, Yang Balakumaran, Arun Marinello, Patricia Miguel, Jesus San |
| author_sort | Mateos, Maria-Victoria |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4646042 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46460422015-11-20 Pembrolizumab (MK-3475) in combination with lenalidomide and low-dose dexamethasone for relapsed/refractory multiple myeloma (RRMM): KEYNOTE-023 Mateos, Maria-Victoria Siegel, David Shah, Jatin J Reece, Donna Avigan, David Orlowski, Robert Ge, Yang Balakumaran, Arun Marinello, Patricia Miguel, Jesus San J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4646042/ http://dx.doi.org/10.1186/2051-1426-3-S2-P160 Text en Copyright © 2015 Mateos et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Mateos, Maria-Victoria Siegel, David Shah, Jatin J Reece, Donna Avigan, David Orlowski, Robert Ge, Yang Balakumaran, Arun Marinello, Patricia Miguel, Jesus San Pembrolizumab (MK-3475) in combination with lenalidomide and low-dose dexamethasone for relapsed/refractory multiple myeloma (RRMM): KEYNOTE-023 |
| title | Pembrolizumab (MK-3475) in combination with lenalidomide and low-dose dexamethasone for relapsed/refractory multiple myeloma (RRMM): KEYNOTE-023 |
| title_full | Pembrolizumab (MK-3475) in combination with lenalidomide and low-dose dexamethasone for relapsed/refractory multiple myeloma (RRMM): KEYNOTE-023 |
| title_fullStr | Pembrolizumab (MK-3475) in combination with lenalidomide and low-dose dexamethasone for relapsed/refractory multiple myeloma (RRMM): KEYNOTE-023 |
| title_full_unstemmed | Pembrolizumab (MK-3475) in combination with lenalidomide and low-dose dexamethasone for relapsed/refractory multiple myeloma (RRMM): KEYNOTE-023 |
| title_short | Pembrolizumab (MK-3475) in combination with lenalidomide and low-dose dexamethasone for relapsed/refractory multiple myeloma (RRMM): KEYNOTE-023 |
| title_sort | pembrolizumab (mk-3475) in combination with lenalidomide and low-dose dexamethasone for relapsed/refractory multiple myeloma (rrmm): keynote-023 |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646042/ http://dx.doi.org/10.1186/2051-1426-3-S2-P160 |
| work_keys_str_mv | AT mateosmariavictoria pembrolizumabmk3475incombinationwithlenalidomideandlowdosedexamethasoneforrelapsedrefractorymultiplemyelomarrmmkeynote023 AT siegeldavid pembrolizumabmk3475incombinationwithlenalidomideandlowdosedexamethasoneforrelapsedrefractorymultiplemyelomarrmmkeynote023 AT shahjatinj pembrolizumabmk3475incombinationwithlenalidomideandlowdosedexamethasoneforrelapsedrefractorymultiplemyelomarrmmkeynote023 AT reecedonna pembrolizumabmk3475incombinationwithlenalidomideandlowdosedexamethasoneforrelapsedrefractorymultiplemyelomarrmmkeynote023 AT avigandavid pembrolizumabmk3475incombinationwithlenalidomideandlowdosedexamethasoneforrelapsedrefractorymultiplemyelomarrmmkeynote023 AT orlowskirobert pembrolizumabmk3475incombinationwithlenalidomideandlowdosedexamethasoneforrelapsedrefractorymultiplemyelomarrmmkeynote023 AT geyang pembrolizumabmk3475incombinationwithlenalidomideandlowdosedexamethasoneforrelapsedrefractorymultiplemyelomarrmmkeynote023 AT balakumaranarun pembrolizumabmk3475incombinationwithlenalidomideandlowdosedexamethasoneforrelapsedrefractorymultiplemyelomarrmmkeynote023 AT marinellopatricia pembrolizumabmk3475incombinationwithlenalidomideandlowdosedexamethasoneforrelapsedrefractorymultiplemyelomarrmmkeynote023 AT migueljesussan pembrolizumabmk3475incombinationwithlenalidomideandlowdosedexamethasoneforrelapsedrefractorymultiplemyelomarrmmkeynote023 |